Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.27B | 54.08B | 55.89B | 50.95B | 39.76B | 36.01B |
Gross Profit | 11.06B | 11.20B | 11.92B | 9.43B | 7.25B | 5.48B |
EBITDA | 5.27B | 5.30B | 6.83B | 4.81B | 3.35B | 1.94B |
Net Income | 2.87B | 2.90B | 3.77B | 2.67B | 2.35B | -143.00M |
Balance Sheet | ||||||
Total Assets | 75.31B | 73.85B | 71.21B | 63.97B | 54.80B | 49.99B |
Cash, Cash Equivalents and Short-Term Investments | 11.48B | 8.76B | 8.49B | 7.09B | 7.35B | 7.50B |
Total Debt | 28.80B | 26.38B | 22.71B | 18.83B | 15.09B | 19.41B |
Total Liabilities | 52.32B | 51.00B | 48.99B | 43.36B | 38.38B | 41.28B |
Stockholders Equity | 22.40B | 22.20B | 21.61B | 20.05B | 15.92B | 8.22B |
Cash Flow | ||||||
Free Cash Flow | 163.00M | -321.00M | -920.00M | -1.66B | 1.02B | 3.23B |
Operating Cash Flow | 2.01B | 1.55B | 386.00M | -523.00M | 2.10B | 4.17B |
Investing Cash Flow | -3.37B | -2.55B | -2.08B | -4.17B | 4.26B | -2.35B |
Financing Cash Flow | 1.05B | 403.00M | 2.93B | 3.33B | -875.00M | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $51.11B | 16.68 | 16.77% | 4.08% | -11.92% | -38.21% | |
77 Outperform | $195.13B | 21.18 | 52.73% | 1.41% | -4.87% | -10.47% | |
70 Outperform | $138.22B | 24.69 | 24.07% | 1.25% | -22.26% | -37.83% | |
69 Neutral | $37.99B | 14.46 | 10.75% | 4.40% | -6.36% | -32.39% | |
69 Neutral | $8.26B | 83.21 | 2.42% | 1.05% | -24.27% | -76.31% | |
66 Neutral | $15.55B | 18.91 | 10.79% | 2.00% | -21.70% | -57.68% | |
62 Neutral | C$7.21B | -0.65 | -4.20% | 2.36% | 10.97% | -26.89% |